Return to Home Incidence > Table > Interpret

Interpretation of Incidence Rates Data

Incidence Rate Report for Idaho by County

Colon & Rectum (Late Stage^), 2017-2021

All Races (includes Hispanic), Both Sexes, Ages 50+

Sorted by Percentlate

Explanation of Column Headers

Objective - The objective of *** is from the Healthy People 2020 project done by the Centers for Disease Control and Prevention.

Incidence Rate (95% Confidence Interval) - The incidence rate is based upon 100,000 people and is an annual rate (or average annual rate) based on the time period indicated. Rates are age-adjusted by 5-year age groups to the 2000 U.S. standard million population.

Percent of Cases with Late Stage - This is the number of late stages cases compared to the number of cases for all stages.


Other Notes


Line by Line Interpretation of the Report


Idaho3


US (SEER+NPCR)1


Elmore County7


Benewah County7


Boundary County7


Jerome County7


Idaho County7


Bannock County7


Madison County7


Gooding County7


Bonneville County7


Shoshone County7


Bingham County7


Gem County7


Franklin County7


Cassia County7


Clearwater County7


Payette County7


Ada County7


Twin Falls County7


Canyon County7


Latah County7


Nez Perce County7


Minidoka County7


Washington County7


Blaine County7


Kootenai County7


Bonner County7


Jefferson County7


Adams County7 Bear Lake County7 Boise County7 Butte County7 Camas County7 Caribou County7 Clark County7 Custer County7 Fremont County7 Lemhi County7 Lewis County7 Lincoln County7 Oneida County7 Owyhee County7 Power County7 Teton County7 Valley County7

Notes:
Created by statecancerprofiles.cancer.gov on 12/11/2024 2:25 pm.

State Cancer Registries may provide more current or more local data.
Trend
Rising when 95% confidence interval of average annual percent change is above 0.
Stable when 95% confidence interval of average annual percent change includes 0.
Falling when 95% confidence interval of average annual percent change is below 0.

† Incidence rates (cases per 100,000 population per year) are age-adjusted to the 2000 US standard population (19 age groups: <1, 1-4, 5-9, ... , 80-84, 85+). Rates are for invasive cancer only (except for bladder cancer which is invasive and in situ) or unless otherwise specified. Rates calculated using SEER*Stat. Population counts for denominators are based on Census populations as modified by NCI. The US Population Data File is used for SEER and NPCR incidence rates.

Rates are computed using cancers classified as malignant based on ICD-O-3. For more information see malignant.html.

^ Late Stage is defined as cases determined to be regional or distant. Due to changes in stage coding, Combined Summary Stage (2004+) is used for data from Surveillance, Epidemiology, and End Results (SEER) databases and Merged Summary Stage is used for data from National Program of Cancer Registries databases. Due to the increased complexity with staging, other staging variables maybe used if necessary.
⋔ Results presented with the CI*Rank statistics help show the usefulness of ranks. For example, ranks for relatively rare diseases or less populated areas may be essentially meaningless because of their large variability, but ranks for more common diseases in densely populated regions can be very useful. More information about methodology can be found on the CI*Rank website.

Φ Rural-Urban Continuum Codes provided by the USDA.
* Data has been suppressed to ensure confidentiality and stability of rate estimates. Counts are suppressed if fewer than 16 records were reported in a specific area-sex-race category. If an average count of 3 is shown, the total number of cases for the time period is 16 or more which exceeds suppression threshold (but is rounded to 3).
1 Source: National Program of Cancer Registries and Surveillance, Epidemiology, and End Results SEER*Stat Database - United States Department of Health and Human Services, Centers for Disease Control and Prevention and National Cancer Institute. Based on the 2023 submission.
3 Source: SEER November 2023 submission. State Cancer Registry also receives funding from CDC's National Program of Cancer Registries.
7 Source: SEER November 2023 submission.

Data for the United States does not include data from Indiana.
Data for the United States does not include Puerto Rico.